Status:

RECRUITING

Virtual Reality as a Digital Premed to Alleviate Pain and Anxiety Preoperatively in Patients Undergoing Spine Surgery

Lead Sponsor:

Medical University of Lodz

Conditions:

Anxiety and Fear

Pain, Postoperative

Eligibility:

All Genders

25-70 years

Phase:

NA

Brief Summary

The aim of this research study is to evaluate the impact of immersive VR exposure on preoperative anxiety and pain. Additionally, to assess whether VR intervention would significantly alleviate pain a...

Eligibility Criteria

Inclusion

  • Adult patients between 25-70 years old, undergoing an elective spinal surgery.
  • Patient's admission prior to surgery day (at least 1 day).
  • Expected hospital stay - 2 days.
  • Capable of providing informed consent and participate in the study follow-up questionnaire.
  • Patients speak Polish.

Exclusion

  • Congestive heart failure, hypertension and anti-hypertensive medications
  • Adrenal insufficiency
  • Alcohol addiction (evaluated by CAGE/AUDIT) and substance addiction (evaluated by DUDIT)
  • Cognitive impairment (evaluated by MMSE, MoCA)
  • Cerebrovascular diseases, ophthalmological diseases (strabismus, diplopia, retina degeneration, glaucoma), neurological conditions (epilepsy or seizure, dementia, vertigo, dizziness, motion sickness) - evaluated by: history taking, examination, vision test (Ishihara test), Simulator Sickness Questionnaire
  • Auditory impairment
  • Psychiatric illness (schizophrenia, bipolar disorder, psychotic depression) - (evaluated by MINI questionnaire)
  • Patients with neuropathic pain
  • Use of sedative drugs, anti-depressants, anxiolytics, and anti-epileptic drugs
  • Intracranial functional lesions (patients after TBI (Traumatic Brain Injury), cognitive or executive dysfunction)
  • Patient with high risk due to major and emergency operations
  • Claustrophobia
  • GCS \< 15

Key Trial Info

Start Date :

August 16 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2026

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT06917300

Start Date

August 16 2024

End Date

September 30 2026

Last Update

April 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Redwan Rahman Jabbar

Lodz, Łódź Voivodeship, Poland, 90-549